This webinar aired live on Wednesday, April 12, 2016 at 2:00PM EST.
Biotech and Pharma are increasingly using quantitative systems pharmacology modeling (QSPM) approaches to help answer complex, critical Go/No-go decisions in R&D. In this webinar Dr. John Burke will discuss:
- The value of QSP approaches
- A QSP industry case study
The case study entails developing and interrogating a QSPM of PD-1 and TIM-3. The QSPM provided:
- Biological insights by predicting why dosing regimens are quite similar for two therapeutics targeting PD-1 that have affinities that differ by several orders of magnitude
- Best-in-class profile predictions for PD-1 and TIM-3 dual antagonists
This webinar is ideal for scientists in R&D who want to learn more about how to leverage QSPM to shorten timelines, lower cost, and increase the likelihood of developing best-in-class drugs.
John M. Burke, PhD | Co-Founder, President and CEO, Applied BioMath